Ultrasound Measure of Gastric Volume in Diabetic and Non Diabetic Patients Before General Anesthesia
NCT ID: NCT03036774
Last Updated: 2020-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
245 participants
INTERVENTIONAL
2017-02-14
2019-02-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Evaluation of Gastric Contents by Antral Ultrasound in Diabetic Patients
NCT04668651
Bedside Gastric Ultrasound for Assessment of ASA Preoperative Starving Guidelines Accuracy: Diabetic vs Non Diabetic Patients
NCT03184532
Gastric Volume in Elderly Patients Undergoing Staged Bilateral Total Knee Arthroplasty
NCT04814706
Effect of Intravenous Dextrose on PONV in Patients Undergoing Gynecological Laparoscopy
NCT05932160
Safety and Efficacy of GPOEM in the Treatment of Gastroparesis
NCT04349670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic patient
Diabetic patients (type 1 or type 2 diabetes) with scheduled surgery . Ultrasonic measurement of antral area
Ultrasonic measurement of antral area
Antral area is measured by ultrasound using a curvilinear abdominal probe of 2-5 MHz and a Logiq E (General Electrics) type echograph or equivalent.
Ultrasound is done before the induction of general anesthesia. Three consecutive measurements of the anteroposterior (AP) and cranio-caudal (CC) diameters are performed.
Antral area (CSA expressed in mm²) is show by the following formula: CSA = AP × CC × π / 4.
Antral area will correspond to the average of the three measures.
Non diabetic patient
Patients with scheduled surgery without history of diabetes or a current, treated or untreated, diabetic disease.
Ultrasonic measurement of antral area
Ultrasonic measurement of antral area
Antral area is measured by ultrasound using a curvilinear abdominal probe of 2-5 MHz and a Logiq E (General Electrics) type echograph or equivalent.
Ultrasound is done before the induction of general anesthesia. Three consecutive measurements of the anteroposterior (AP) and cranio-caudal (CC) diameters are performed.
Antral area (CSA expressed in mm²) is show by the following formula: CSA = AP × CC × π / 4.
Antral area will correspond to the average of the three measures.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasonic measurement of antral area
Antral area is measured by ultrasound using a curvilinear abdominal probe of 2-5 MHz and a Logiq E (General Electrics) type echograph or equivalent.
Ultrasound is done before the induction of general anesthesia. Three consecutive measurements of the anteroposterior (AP) and cranio-caudal (CC) diameters are performed.
Antral area (CSA expressed in mm²) is show by the following formula: CSA = AP × CC × π / 4.
Antral area will correspond to the average of the three measures.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) classification 1 to 3
* Needed a general anesthesia for a programmed surgical intervention
* Respect of instructions of the pre-operative fasting;
* Affiliation to the social security;
* Consent form signed
* Pregnant or breastfeeding women
* Patients already operated or to be operated from the upper digestive tract (esophagus, stomach, duodenum)
* Patients treated with a prokinetic treatment and / or a level 3 analgesic
Exclusion Criteria
* Failure to observe fasting instructions
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julien Rousset, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Tenon
Marc Fischler, MD-PhD
Role: STUDY_CHAIR
Hôpital Foch
Francis Bonnet, MD-PhD
Role: STUDY_CHAIR
HopitalTenon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Ophtalmologique Adolphe de Rotschild
Paris, , France
AP-HP Hopital Tenon
Paris, , France
Hopital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A01997-47
Identifier Type: OTHER
Identifier Source: secondary_id
2014/30
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.